Erin LeBlanc, MD, MPH

• Degrees:
  MD: Yale University School of Medicine,1995
  MPH: Oregon Health & Science University,1999
• Residency:
  Internal Medicine, Stanford University School of Medicine, 1998
• Fellowship:
  Women’s Health Fellowship, Portland Veteran's Affairs Medical Center, 2000; Endocrinology, Oregon Health & Science University, 2003.

• Biosketch:
  My overall research interest is the role of sex hormones in the development of disease. Currently, I am interested in the effects of estradiol loss on the brain and the role that estradiol loss plays in the development of perimenopausal symptoms. My current research is on the effects of estradiol supplementation on cognition, mood, symptoms, and sleep in the perimenopausal period.

• Publications:

  Nelson H, Humphrey L, LeBlanc E, Miller J, Takano L, Chan BKS, Nygren P, Allan J, Teutsch S. Postmenopausal Hormone Replacement Therapy for Primary Prevention of Chronic Conditions. Summary of the Evidence for the U.S. Preventive Services Task Force. Rockville, MD: Agency for Healthcare Research and Quality; August 2002.

  LeBlanc ES, Janowsky J, Chan BKS, Nelson HD. Hormone Replacement Therapy and Cognition: Systematic Review and Meta-analysis. JAMA. 2001;285:1489-1499.

  LeBlanc ES, Laws A. Benefits and risks of third-generation oral contraceptives. Journal of General Internal Medicine. 1999; 14(10):625-32.

  LeBlanc ES, Henrich JB, Viscoli C. Postmenopausal estrogen replacement therapy is associated with adverse breast cancer prognostic indices. Journal of Womens Health & Gender-Based Medicine. 1999; 8(6):815-23.

  Scalley EK*, Henrich JB. An overview of estrogen replacement therapy in postmenopausal women. Journal of Women's Health 1994; 2:289-94.

• All Publications

This site last updated 1/6/04.
Send your comments about the site to the Web Manager.